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ABSTRACT
Background During the coronavirus disease 2019 (COVID-19) epidemic, many countries have instituted
population-wide measures for social distancing. The requirement of patients on dialysis for regular treat-
ment in settings typically not conducive to social distancing may increase their vulnerability to COVID-19.
MethodsOver a 6-week period, we recorded newCOVID-19 infections and outcomes for all adult patients
receiving dialysis in a large dialysis center. Rapidly introduced control measures included a two-stage
routine screening process at dialysis entry (temperature and symptom check, with possible cases segre-
gated within the unit and tested for SARS-CoV-2), isolated dialysis in a separate unit for patients with
infection, and universal precautions that included masks for dialysis nursing staff.
Results Of 1530 patients (median age 66 years; 58.2% men) receiving dialysis, 300 (19.6%) developed
COVID-19 infection, creating a large demand for isolated outpatient dialysis and inpatient beds. An anal-
ysis that included 1219 patients attending satellite dialysis clinics found that older age was a risk factor for
infection. COVID-19 infection was substantially more likely to occur among patients on in-center dialysis
comparedwith those dialyzing at home.Weobserved clustering in specific units and on specific shifts, with
possible implications for aspects of service design, and high rates of nursing staff illness. A predictive
epidemic model estimated a reproduction number of 2.2; cumulative cases deviated favorably from the
model from the fourth week, suggesting that the implemented measures controlled transmission.
Conclusions The COVID-19 epidemic affected a large proportion of patients at this dialysis center, creat-
ing service pressures exacerbated by nursing staff illness. Details of the control strategy and characteris-
tics of this epidemic may be useful for dialysis providers and other institutions providing patient care.
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Following the appearance of a novel coronavirus
(severe acute respiratory syndrome coronavirus 2
[SARS-CoV-2]) and its associated disease (corona-
virus disease 2019 [COVID-19]) in Wuhan, China
on December 27th,1 there has been rapid viral dis-
semination leading to a global pandemic. COVID-19
is highly contagious, and human-to-human trans-
mission has been recognized from the outset.2,3 As
a result, quarantine measures have played a central
role in controlling cluster outbreaks, particularly in
confined locations.4 With evidence of significant
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presymptomatic transmission,5many countries have instituted
population-wide policies to increase social distance, often
termed “lockdown.”
The treatment of many long-term conditions requires reg-
ular contact with health care staff, preventing social distanc-
ing. Most patients receiving hemodialysis need to continue to
attend their dialysis unit three times per week, where they
encounter nursing staff and a number of other patients. More-
over, this predominantly elderly population has a high burden
of comorbidity, including cardiovascular disease and diabetes:
these are associated with a higher case-fatality rate6 in those
with COVID-19. This combination makes the delivery of di-
alysis uniquely challenging in the face of the pandemic.
Though dialysis-specific guidance on COVID-19 is
available,7–9 there is limited published experience of
COVID-19 in dialysis populations. A single-center report
from Wuhan (Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L,
et al. [2020] 2019 Novel coronavirus disease in hemodialysis
[HD] patients: Report from one HD center in Wuhan, China.
10.1101/2020.02.24.20027201) described an outbreak of 37
cases from a dialysis population of over 200, which was
brought under control with radical measures. In two other
coronavirus diseases (severe acute respiratory syndrome and
Middle East respiratory syndrome), transmission during di-
alysis was reported, but both epidemics were substantially
smaller than COVID-19.10,11
The first laboratory-confirmed case of COVID-19 in the
United Kingdom occurred on January 30th. The United King-
dom, with a largely urban-centered epidemic, has responded
with progressive social distancing measures, including the clo-
sure of social venues and schools from March 20th. We report
the effect of the epidemic on a large urban dialysis population,




Imperial College Healthcare NHS Trust provides RRTs for a
catchment population of 2.5 million living in northwest Lon-
don, including over 1500 patients on dialysis.12 Dialysis care is
delivered from a central hospital (with inpatient wards, a hos-
pital dialysis unit, and an area for training and supervision of
patients on home dialysis) with eight satellite hemodialysis
units in other locations. Institutional transport is provided
for patients unable to travel to dialysis, with up to six patients
sharing a vehicle. Home dialysis includes peritoneal dialysis
and home hemodialysis.
Study Design
This was a cohort study in which data were collected from
electronic records from hospitals and dialysis units. The ser-
vice evaluation and analysis were approved by the Renal Qual-
ity and Safety (Governance) Committee of Imperial College
Healthcare NHS Trust in view of the project being an evalua-
tion of a service change during the COVID-19 pandemic. Only
fully anonymized patient data were used.
Study Population
The cohort included all adults with established renal failure
treated with dialysis in satellite units, in the hospital, or at
home starting before March 1st, 2020.
Outcome Assessment
Patient data were collected over 6 weeks from March 9th to
April 19th, 2020, including all dialysis attendance and all
admissions to hospital of cohort patients. Infection with
SARS-CoV-2 was confirmed through real-time RT-PCR assay
of nasopharyngeal swab specimens, and only laboratory-
confirmed cases are included in the analysis.
Covariate Definitions
Dialysis unit, shift (day/time), and transplant status (active,
suspended, or not listed) were defined at the start of the ob-
servation period. There was no loss to follow-up. Data were
complete apart from ethnic status in 1.2% (excluded from the
Cox model) and institutional transport: status was complete,
but vehicle allocation was available only for 77.8%. Commu-
nity risk of COVID-19 infection was determined by identify-
ing the upper tier local authority for each patient’s domestic
address combined with COVID-19 cumulative incidence by
the end of the observation period for each local authority13
standardized against population size, divided into low-, me-
dium-, and high-risk categories. Satellite unit area was defined
as the total floor area of both dialysis delivery rooms and wait-
ing rooms divided by the number of available dialysis stations.
Station distance was defined as the linear (sight-line) distance
between a station and the nearest neighboring station (mea-
sured from the center of each chair).
Statistical Analyses
Covariate data were compared using unpaired t tests and chi-
squared tests. Multivariable Cox proportional hazards models
assessed risk factors for acquisition of COVID-19 in patients
Significance Statement
Social distancing is an important tool in preventing the spread of
SARS-CoV-2 during the COVID-19 pandemic. Dialysis centers that
treat patients undergoing hemodialysis typically are not conducive
to social distancing, and there is limited published experience
available for guidance. The authors describe control measures—
including universal protective equipment, a regular screening pro-
cess, and case isolation—implemented during a rapidly developing
COVID-19 epidemic in a large dialysis center, as well as service
pressures experienced. Risk factors for infection included older age
and infection rates within specific satellite units; aspects of unit
design might help explain clustering of cases in those units. After
the third week, COVID-19 cases fell short of the projected epidemic
course, suggesting that control was achieved and that early adop-
tion of control measures can help protect patients.
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treated in satellite hemodialysis units, with proportional haz-
ards assumption tested by Schoenfeld residuals. Factors with a
P value ,0.10 on univariate analysis were entered into the
model. The expected distribution of infection among occu-
pants in shared institutional transport was calculated using the
binomial distribution using the observed incidence across sat-
ellite units. Funnel plot control limits were calculated using a
normal approximation of the binomial distribution. The
basic reproduction number R0 was estimated from log cu-
mulative case number by least squares regression using a
serial interval of 4 days. Epidemic modeling was performed
in Excel with susceptible-infectious-removed (SIR) com-
partments, and all patients were assumed to be susceptible
at the start, with transmission according to the equation
S(t11)5S(t)–b3S(t)3I(t)/N.
RESULTS
The first COVID-19 case was identified on March 13th.
Over the next 6 weeks, of 1530 patients (median age 66;
58.2% men) receiving dialysis, 300 developed infection
with SARS-CoV-2 (19.6%). Most patients (290) were re-
ceiving in-center hemodialysis before the start of the epi-
demic, but 8 were on peritoneal dialysis and 2 were on home
hemodialysis, with patient characteristics given in Table 1.
Most infectionwas acquired outside the hospital setting, but
12 patients acquired infection after hospital admission for a
non–COVID-19 condition.
Tests for SARS-CoV-2 were carried out according to
clinical indication and local practice in those presenting to
hospital services and following screening in dialysis units
(Figure 1). A routine two-stage screening process was intro-
duced at every dialysis session for every patient at the start of
the observation period from March 9th. Patients were first
screened by temperature and symptom inquiry: those with
possible COVID-19 were segregated immediately within the
dialysis unit and tested for SARS-CoV-2 by nasopharyngeal
swab taken during dialysis. Unless hospitalized on the basis of
Table 1. Clinical characteristics of patients
Characteristics Total Population COVID-19 Cases
No. (% of total cohort) 1530 (100) 300 (19.6)
Age, yr, median (IQR) 66 (55–75) 67 (57–77)
Sex (%)
Men 891 (58.2) 180 (60.0)
Women 639 (41.8) 120 (40.0)
Ethnicity (%)
Asian 642 (42.0) 137 (45.7)
White 470 (30.7) 84 (28.0)
Black 402 (26.2) 75 (25.0)
Unknown 28 (1.2) 4 (1.3)
Diabetes (%) 696 (45.4) 155 (51.7)
Mode of dialysis (%)
Satellite unit HD 1222 (79.9) 273 (91.0)
Hospital HD 128 (8.3) 17 (5.67)
Home dialysis, HD or PD 180 (11.7) 10 (3.33)
Access
Peritoneal catheter 155 (10.1) 8 (2.7)
Fistula 384 (25.1) 82 (27.3)
Graft 19 (1.2) 7 (2.3)
Tunneled vascular catheter 972 (63.5) 203 (67.7)
Institutional transport (%) 675 (44.1) 163 (54.3)
Nursing home (%) 29 (1.8) 5 (1.7)
























































Figure 1. Epidemic timeline by incident patient testing. Epidemic timeline in patients on dialysis showing counts of patients with
symptoms suggestive of COVID-19 and testing for SARS-CoV-2 according to date of test. From March 10, all patients on in-center
hemodialysis were screened before each dialysis session (symptom questions and temperature) to select those for SARS-CoV-2 testing
and dialysis in a segregated area of the unit: patients with positive tests were treated in a dedicated isolation unit starting from their
next session. Tests were performed as clinically indicated in patients on home dialysis and those presenting to hospital emergency
departments.
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clinical decision, patients with positive tests were then treated
in isolation at a separate unit specifically for patients carrying
SARS-CoV-2 starting from their next dialysis session. Initially,
a hospital ward was used, but from March 17th, a dedicated
isolation unit was opened (by displacing patients to an evening
shift in another satellite unit); two further hemodialysis iso-
lation units were similarly opened on March 30th and April
8th. There was no screening process for patients on home
dialysis who may have had minor symptoms without present-
ing to hospital services. From a total of 457 tests for SARS-
CoV-2 carried out in the cohort, including 363 in dialysis units
following positive symptom report on screening, 65.6% were
positive. Nineteen patients with a positive test also had a pre-
vious negative test carried out at a median (interquartile range
[IQR]) of 9 (5–17) days earlier.
Nursing staff members in isolation units wore enhanced
protective equipment, including sleeved gowns and FFP3
masks. Nursing staff members in other units wore surgical
masks for all patient contact from the third week. Dialysis staff
members were encouraged to report any febrile illness and to
self-isolate at home for at least 7 days. For themajority of staff,
no confirmatory test for SARS-CoV-2 was carried out in ac-
cordance with national guidance.
Following diagnosis, patients on in-center hemodialysis
who were not hospitalized were isolated for outpatient dial-
ysis for at least 14 days. Deisolation was considered after
14 days in patients without fever or ongoing symptoms,
with first nonisolated dialysis occurring at median (IQR) in-
terval of 18 (14–28) days after diagnosis. This led to a need for
isolated outpatient dialysis, which peaked at 135 patients
during week 4 and started to diminish during the sixth
week (Figure 2).
By the end of the observation period, after a median (IQR)
postdiagnosis period of 21 (14–26) days, 239 patients with
COVID-19 survived (79.7%), with 51 patients (17.0%) re-
maining in the hospital (Figure 2). Compared with those sur-
viving, patients who died were older (72.0 versus 63.9 years;
P,0.001) and less likely to be recorded as currently active on
the deceased donor transplant register (10.7% versus 25.6%;





































Figure 2. Cumulative counts of patients positive for SARS-CoV-2 according to clinical status and absent nursing staff during the
epidemic between March 9 and April 20, 2020. (A) Clinical status of all patients on dialysis developing COVID-19. Patients on in-center
hemodialysis who were not hospitalized were isolated for outpatient dialysis for at least 14 days. Prior to March 17, a hospital ward was
used, after which three dedicated isolation units were created (arrows) by moving patients between units. (B) Absence from work due to
illness (usually without SARS-CoV-2 testing) in dialysis nursing staff.
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to sex, weight, ethnicity, comorbidity (diabetes), or dialysis
duration.
Risk factors for SARS-CoV-2 infection were analyzed for
patients attending satellite hemodialysis units (n51219;
median age 66; 59.8% men); infection developed in 270
(22.1%). Compared with those unaffected, patients with de-
tected infection were slightly older (67.2 versus 64.9;
P50.02). There was no evidence of a difference in sex, co-
morbidity (diabetes), dialysis duration, or activity on the
deceased donor transplant register, and there was no evi-
dence of a difference in infection proportion between eth-
nicities or differing levels of community infection according
to residential location (Table 2). The use of institutional
transport to attend dialysis was not associated with risk of
infection, and there was no evidence of infection clustering
within vehicle groups, with the distribution of infection
among occupants closely resembling that expected by ran-
dom dispersion (Table 3).
Between satellite units, differences in the proportions de-
veloping infection were observed, ranging from 5.6% to
41.5%. Age and dialysis unit were independently predictive
of time to infection in a Cox proportional hazards model
(Table 2). The role of chance in unit variability is visually
demonstrated using a funnel plot to define control limits
on the expected variation by unit size (Figure 3A). Possible
explanations for unit differences were explored, including
the proportion of self-reported staff illness, which followed
the same pattern as patient infection (R50.89; P50.007).
The satellite unit with the smallest number of infections
was also the most spacious, but evidence of a linear relation-
ship generally between unit space and infection was not seen
(Table 4).
Infection proportion also differed between the 39 specific
dialysis-unit shifts, ranging from 0.0% to 68.0%. Shift infec-
tion was associated with underlying unit infection
(Figure 3B), suggesting that part of the variation between
Table 2. Risk factors for time to COVID-19 infection in patients attending satellite dialysis units (n51219)
Variable
Univariable Multivariable
Unadjusted HR (95% CI) P Value Adjusted HR (95% CI) P Value
Variables included
Age, per decade increase 1.11 (1.02 to 1.21) 0.02 1.09 (0.99 to 1.20) 0.06
Unit, reference Unit D
Unit A 0.24 (0.11 to 0.50) ,0.001 0.24 (0.12 to 0.51) ,0.001
Unit B 0.67 (0.38 to 1.18) 0.17 0.68 (0.39 to 1.21) 0.22
Unit C 1.02 (0.66 to 1.59) 0.91 1.01 (0.65 to 1.57) 0.97
Unit E 1.07 (0.76 to 1.49) 0.71 1.04 (0.75 to 1.46) 0.81
Unit F 1.14 (0.72 to 1.81) 0.56 1.14 (0.72 to 1.81) 0.57
Unit G 2.20 (1.52 to 3.18) ,0.001 2.20 (1.52 to 3.18) ,0.001
Variables excluded
Sex, women 0.97 (1.03 to 1.24) 0.81
Ethnicity, reference Asian
Black 0.87 (0.64 to 1.17) 0.35
White 0.91 (0.68 to 1.20) 0.50
Diabetes 1.23 (0.97 to 1.57) 0.08
Transport, institutional 1.12 (0.88 to 1.42) 0.37
Vascular access, other versus catheter 0.95 (0.74 to 1.23) 0.71
Community risk, reference medium
Low 1.06 (0.76 to 1.49) 0.72
High 0.90 (0.68 to 1.19) 0.44
Community risk is defined by residential address. HR, hazard ratio; 95% CI, 95% confidence interval.




Groups of This Type
No. of Patient Occupants
Developing COVID-19
0 1 2 3 4 5
1 56 43 (43.5) 13 (12.5)
2 49 27 (29.6) 19 (17.0) 3 (2.4)
3 66 30 (31.0) 23 (26.6) 10 (7.7) 3 (0.7)
4 32 13 (11.7) 12 (13.4) 5 (5.8) 1 (1.1) 1 (0.1)
5 9 3 (2.5) 2 (3.6) 3 (2.1) 1 (0.6) 0 (0.1) 0 (0.0)
Data are the number of vehicle groups in each category given as observed (expected). Expected values are calculated from the binomial distribution, with
probability 0.221. Number of patients 5525. Number of vehicle groups 5212.
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shifts was explained by variation between units. Evidence for
“vertical” transmission (e.g., from morning to afternoon pa-
tients in the same unit) was not observed, with no association
between infection proportions in adjacent shifts within units
(R520.16; P50.33).
Using cumulative case numbers from the first 2 weeks, an
initial reproduction number was estimated (R052.2), and an
SIR model using this value was fitted to the observed number
of cases at the end of the second week. The model predicted
case numbers accurately during the third week, but
thereafter, substantial deviation started
to occur, with fewer cases observed than
predicted by the model (Figure 4).
DISCUSSION
We report the abrupt appearance of
COVID-19 within an urban dialysis center,
showing its effect in a population unable to
remain isolated at home. Although the ep-
idemic was anticipated, it brought multiple
challenges for the protection and safe treat-
ment of patients needing dialysis. The
characteristics of the epidemic in this
setting are therefore worthy of detailed
analysis, with implications for dialysis pro-
viders as well as other institutions where
self-isolation is not possible, such as pris-
ons and long-term care facilities.14
In the dialysis population described,
COVID-19 was seen in over 20% of patients within 6 weeks
of the first detected case. In contrast, by the end of obser-
vation, infection had been detected in ,0.5% of the local
adult population, and accounting for nondetected illness, it
was estimated to have affected ,5% of the population.13
Infection may be more severe and therefore, more often
detected in populations with long-termmedical conditions,
particularly when screening for symptoms and fever, or al-
ternatively, infection may be more commonly asymptom-
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Figure 3. Variation in infection proportion between satellite unit and shift. (A) Funnel
plot showing unit infection by unit size (number of patients) for the seven nonisolation
satellite units (indicated as A–G), with hospital dialysis (indicated as H) and home di-
alysis (indicated as I) included for comparison along with 90% (solid lines) and 99%
(dashed lines) control limits. (B) Infection in specific shifts (n539) of satellite units by
proportion with infection in the whole unit, with linear regression line.




A B C D E F G
COVID-19 diagnosis
Shift 1, N/at risk 3/48 6/36 13/54 21/109 24/117 12/44 21/50
Shift 2, N/at risk 3/48 7/36 14/53 33/115 35/120 14/44 22/48
Shift 3, N/at risk 2/46 2/28 1/24 7/47 19/102 0/18 11/32
COVID-19 cases, % of unit 5.6 15.0 21.4 22.5 23.0 24.5 41.5
COVID-19 exposure
Date of first case (March) 19th 17th 14th 14th 13th 21st 16th
Staff illness, % 35.7 40.0 43.2 56.0 60.7 72.7 84.0 0.90 0.006
Community COVID-19, % 0.18 0.22 0.33 0.24 0.28 0.14 0.23 0.16 0.73
Patient population
Age 61.4 (14.4) 64.4 (13.6) 66.9 (13.4) 64.7 (14.3) 66.7 (14.3) 65.4 (14.4) 63.3 (13.8) 0.25 0.59
Ethnicity, % Asian/black 68.3 65.3 84.2 72.7 76.5 37.9 76.1 0.10 0.83
Diabetes, % 49.7 36.0 45.8 43.9 47.6 46.7 50.8 0.33 0.47
Unit size
Stations 24 19 28 66 62 22 25 0.08 0.86
Dialysis space, m2 per station 15.2 9.2 11.0 13.6 11.3 9.9 10.5 20.48 0.27
Waiting room, m2 per station 2.8 0.9 1.6 1.4 1.3 1.9 0.9 20.65 0.11
Station distance, m 3.0 (0.6) 2.1 (0.4) 2.1 (0.3) 2.3 (0.1) 1.8 (0.3) 1.9 (0.2) 1.9 (0.1) 20.74 0.06
All correlations are between the variable of interest and proportion of patients with COVID-19. Age and station distance are given as mean (SD). Station distance is
defined as the linear distance to the nearest neighboring station measured from the center of each chair. R, Pearson correlation coefficient.
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estimated R0 of 2.2 is similar to that observed in other local
COVID-19 epidemics; therefore, infection does not seem to
be accelerated in this group. The relative sparing of patients
on home dialysis suggests that transmission may be occur-
ring particularly in those receiving in-center hemodialysis.
Variation in risk between units may result from random
variation in the introduction of infection from the commu-
nity, but it also supports the possibility of within-unit trans-
mission, suggesting that to understand this epidemiology,
one might examine unit-level factors, such as nursing prac-
tices, unit design, and transport.
Though variation in transmission was observed, nursing
practices are uniform across the satellite dialysis units studied.
The variation observed between shifts suggests that any
within-unit transmission is predominantly horizontal (within
dialysis shifts) rather than vertical (from one shift to the next).
Vertical transmission might be one’s main concern given the
evidence of dispersion of SARS-CoV-2 on surfaces within
health care settings15 and viral persistence16 on plastics, but
this is reduced by well established cleaning practices to prevent
blood-borne virus transmission.
Nursing practices cannot prevent airborne droplet trans-
mission as patients arrive, dialyze, and leave, spending 5 or
more hours in the unit, during which time SARS-CoV-2 re-
mains viable.16 Given that droplets and aerosols can disperse
.2 m,17 unit design is a more likely explanation for some of
the variation: for example, the threefold difference between
waiting area size of units A and G. Though no clear association
between unit area and infection was observed, this study may
be too small to detect the effect of unit size, which is likely to
play a role inmaintaining transmission despite the implemen-
tation of control measures.
The high rate of staff illness, mostly without confirmatory
testing, is explained by responsible self-isolation in line with
United Kingdom government advice, though some of this may
not have been due to COVID-19. Dialysis staff risks have been
noted in other infections, ranging fromhepatitis at the inception
of hospital-based dialysis18 toMiddle East respiratory syndrome
coronavirus more recently.19 Nursing illness was variable, with
absences for the whole period ranging from 35% to 84% of staff
in different units; it was not possible to infer the direction of the
relationship, if any, between infection in patients and staff. How-
ever, the shared environment of patients and staff is highlighted
by the similarity of their illness distributions.
One could speculate that universal screening of all patients
might have mitigated transmission, particularly from pre-
symptomatic patients,20 but this would have overwhelmed
testing facilities available at the time. Screening clinically rather
than by virus detection was also contemplated—a Wuhan di-
alysis unit reported screening the entire dialysis population
(and all staff) using chest computed tomography21—but this
was considered impractical. Because asymptomatic transmis-
sion is well recognized,22,23 with heavy viral shedding before
















































Figure 4. Deviation from predictive model suggesting control of the epidemic. Cumulative number of COVID-19 cases between
March 9 and April 20. Observed cumulative cases (log scale) starting from the tenth case alongside the modeled epidemic curve
assuming an R0 of 2.2 (solid line), showing deviation from predicted course after the third week. The total dialysis population is also
shown (dashed line).
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dialysis session previous to diagnosis, and universal precau-
tions, including the use of simple surgical masks, may be the
most effective measures.24 Surgical masks were routinely used
by nurses in all dialysis units from the third week, but masks
were generally not in routine use for patients during the ob-
servation period, including on institutional transport.
Other suggested options for reducing transmission8 were
considered but not adopted: reducing dialysis frequency may
have improved distancing within units, but there was concern
that patients might be more vulnerable at the onset of infec-
tion. Opening nonstandard shifts, such as overnight, might
similarly have improved distancing but would have further
stretched a nursing group already depleted by illness.
Only a single center was studied, albeit one with several sat-
ellite units, which limits the generalizability of conclusions, but it
carries the advantage of uniformity of clinical practice across the
study. Control lines in the funnel plot are likely to be too con-
servative due to overdispersion of results, and more centers
would be needed to derive accurate confidence limits for outlier
detection. The study was not primarily designed to assess mor-
tality, and though age-specific survival seems broadly similar to
other comorbid groups,25 no firm conclusions can be drawn:
survival data presented should be interpreted with caution.
Dialysis centers experiencing cases of COVID-19 may pre-
vent spread within units by the early adoption of universal
protective equipment, a regular patient screening process,
and case isolation, though there is no way of assessing the
effectiveness or otherwise of interventions adopted in this
study. Analysis of cumulative case numbers did suggest a de-
parture from the epidemic course predicted from the early R0
estimation of 2.2, an estimation comparable with COVID-19
outbreaks in cruise ships.26 Three theories could explain this
apparent reduction in expected cases. First, the control mea-
sures adoptedmay have been sufficient to substantially modify
transmission, with the effect only expected after an interval of
2–3 weeks. Second, reduced numbers may reflect control of
the epidemic within the wider community. Third, departure
from the prediction may reflect limitations of SIR modeling,
which assumes homogenous mixing and uniform susceptibil-
ity across a large population. In moderate-sized dialysis units
with significant interpatient variability, these assumptions
may not be valid,27 and models with variable susceptibility
would predict a course closer to that observed.
COVID-19 caused an abrupt epidemic in this group of
patients whose essential treatment makes them vulnerable.
Details of the control strategy adopted, transmission charac-
teristics, and epidemic course are of relevance to dialysis pro-
viders and other institutions as they face the same viral threat.
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